rs1863704
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015690.5(STK36):c.3008G>A(p.Gly1003Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 1,613,918 control chromosomes in the GnomAD database, including 108,220 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_015690.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK36 | NM_015690.5 | c.3008G>A | p.Gly1003Asp | missense_variant | 25/27 | ENST00000295709.8 | NP_056505.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK36 | ENST00000295709.8 | c.3008G>A | p.Gly1003Asp | missense_variant | 25/27 | 1 | NM_015690.5 | ENSP00000295709.3 |
Frequencies
GnomAD3 genomes AF: 0.278 AC: 42250AN: 151954Hom.: 7488 Cov.: 32
GnomAD3 exomes AF: 0.319 AC: 80264AN: 251388Hom.: 14424 AF XY: 0.325 AC XY: 44094AN XY: 135866
GnomAD4 exome AF: 0.362 AC: 529721AN: 1461846Hom.: 100732 Cov.: 52 AF XY: 0.360 AC XY: 261769AN XY: 727224
GnomAD4 genome AF: 0.278 AC: 42249AN: 152072Hom.: 7488 Cov.: 32 AF XY: 0.277 AC XY: 20556AN XY: 74308
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 06, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at